Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

NAfrAM

Financiado

Novel antibiotics from Antarctic microbes

Microbial resistance to antimicrobial compounds has become one of the biggest threats to global health. The inability to treat infectious diseases poses a severe threat to human health, and the costs associated with antimicrobial... ver más

30/09/2024

190K€

Presupuesto del proyecto: 190K€

Líder del proyecto

EBERHARD KARLS UNIVERSITAET TUEBINGEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-09-30

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2021-PF-01-01: MSCA Postdoctoral Fellowships 2021

I+D

Cerrada hace 3 años

0% 100% 100%

1 Participantes

189.69K€ | Lider

Proyectos interesantes

ENABLE European Gram Negative Antibacterial Engine 101M€ Cerrado

BFU2017-90030-P APUNTANDO A LA RESISTENCIA A ANTIBIOTICOS: BASES ESTRUCTURAL... 387K€ Cerrado

D_Bug Innovative Antibiotics to target drug resistant microbes 150K€ Cerrado

BES-2014-070297 DESARROLLO DE NUEVOS ANTIBIOTICOS PARA EL TRATAMIENTO DE INF... 88K€ Cerrado

PID2019-108643GA-I00 ABORDANDO LA RESISTENCIA ANTIMICROBIANA MEDIANTE ESTRUCTURAS... 85K€ Cerrado

IJCI-2016-29920 Enfermedades Infecciosas y Microbiología. Mecanismos bacteri... 64K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 27 meses Fecha Inicio: 2022-06-01
Fecha Fin: 2024-09-30

Líder del proyecto

EBERHARD KARLS UNIVERSITAET TUEBINGEN

TRL 4-5

Presupuesto del proyecto 190K€

Descripción del proyecto Microbial resistance to antimicrobial compounds has become one of the biggest threats to global health. The inability to treat infectious diseases poses a severe threat to human health, and the costs associated with antimicrobial resistance (AMR) are immense. The severity of AMR is emphasized by implementing the fight against AMR into major goals of the United Nations, European Union, or World Health Organization. One of the major issues with AMR is the long-term decline in the development of novel antibiotics; thus, new antibiotics are urgently needed. Microbes living in the harsh condition of Antarctica represent a promising new source that is worth exploring for new antibiotics. Recent studies showed a significant genetic divergence of Antarctic microbes from other microbes worldwide and suggested the enormous potential of these microbes to produce novel bioactive metabolites. Therefore, the main goals of this project are devoted to the characterization of the overall biosynthetic potential hidden within different Antarctic microbial communities through identification of a broad spectrum of the biosynthetic gene cluster (BGC), determination of their diversity, phylogeny, and environmental distribution, followed by target genome mining for the discovery of BGC producing new antibiotics. The acquired knowledge will then be used for the heterologous expression of antibiotic BGC in a suitable host, followed by compounds isolation, bioactivity verification, and the elucidation of the structure. To pursue the raised objectives, interdisciplinary methods will be integrated, such as bioinformatics, molecular/synthetic biology, and analytical chemistry. Such an interdisciplinary project will provide the applicant with excellent training in both scientific and transferable skills. Together with the applicants' participation in the excellent national and international network of the supervisor, Prof. Ziemert, will significantly enhance the applicant's career perspectives.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores